Cancer Treatment Response to Checkpoint Inhibitors Is Associated with Cytomegalovirus Infection

Programmed cell death protein-1 (PD-1) and programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors induce tumor response by activating the patient’s own immune system to fight cancer. Tumors with high tumor mutational burden or those that express high levels of PD-1/PD-L1 are more responsive to...

Descripción completa

Detalles Bibliográficos
Autores principales: Villanueva, Faith, Yuan, Cai, Drane, Walter, Dang, Long, Nguyen, Thu-Cuc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026877/
https://www.ncbi.nlm.nih.gov/pubmed/32104613
http://dx.doi.org/10.7759/cureus.6670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026877/
https://www.ncbi.nlm.nih.gov/pubmed/32104613
http://dx.doi.org/10.7759/cureus.6670

Ejemplares similares